Metabolomics for the identification of biomarkers in endometriosis

Background Endometriosis affects the quality of life in women during their reproductive years, causing immense pain and can result in infertility. It is characterized by inflammation and the growth of the endometrium outside the uterine cavity. Metabolomics has the potential to resolve the major bottleneck of endometriosis which is delay in diagnosis due to the invasive diagnostic approach.In this review, the author has summarized the identified biomarkers of endometriosis from different bodily fluids. Metabolomics promises a non-invasive diagnostic approach for endometriosis that could aid in earlier diagnosis and prognosis.

Patients with endometriosis keywords were searched in correspondence with the assigned keywords, including metabolomics from PubMed, from its inception to Dec 2023. The relevant studies from this search were extracted and included in the study.

This article provides information regarding metabolomics studies in endometrisis.

We demonstrated that metabolomics is about to change the world of endometriosis by analyzing and detecting the diagnosis, prognosis, mortality and treatment response biomarkers. Similar content being viewed by others Data availability Not applicable Code availability Not applicable

Giudice LC, Kao LC (2004) Endometriosis. Lancet. 364(9447):1789–1799 Angioni S (2017) New insights on endometriosis. Minerva Ginecol 69(5):438–439 Mehedintu C, Plotogea MN, Ionescu S, Antonovici M (2014) Endometriosis still a challenge. J Med Life 7(3):349–357 Centini G, Ginetti A, Colombi I, Cannoni A, Giorgi M, Ferreira H et al (2024) Endometriosis of the appendix: prevalence, associated lesions, and proposal of pathogenetic hypotheses. A retrospective cohort study with prospectively collected data. Arch Gynecol Obstet 310(3):1669–75 Appleyard CB, Cruz ML, Hernandez S, Thompson KJ, Bayona M, Flores I (2015) Stress management affects outcomes in the pathophysiology of an endometriosis model. Reprod Sci 22(4):431–441 Parasar P, Ozcan P, Terry KL (2017) Endometriosis: epidemiology, diagnosis and clinical management. Curr Obstet Gynecol Rep. 6(1):34–41 Kiesel L, Sourouni M (2019) Diagnosis of endometriosis in the 21st century. Climacteric 22(3):296–302 Wischmann TA-O, Ditzen B (2024) Endometriosis: patient-doctor communication and psychological counselling. Arch Gynecol Obstet 309(2):599–610 Dutta M, Singh B, Joshi M, Das D, Subramani E, Maan M et al (2018) Metabolomics reveals perturbations in endometrium and serum of minimal and mild endometriosis. Sci Rep 8(1):6466 Li J, Guan L, Zhang H, Gao Y, Sun J, Gong X et al (2018) Endometrium metabolomic profiling reveals potential biomarkers for diagnosis of endometriosis at minimal-mild stages. Reprod Biol Endocrinol 16:42 Singh M, Jassal R, Khetarpal P (2024) Diagnostic and therapeutic approaches for endometriosis: a patent landscape. Arch Gynecol Obstet 309(3):831–842 Wang Z, Zhu C, Nambi V, Morrison AC, Folsom AR, Ballantyne CM et al (2019) Metabolomic pattern predicts incident coronary heart disease. Arterioscler Thromb Vasc Biol 39:1475–1482 Pallares-Mendez R, Aguilar-Salinas CA, Cruz-Bautista I, Del Bosque-Plata L (2016) Metabolomics in diabetes, a review. Ann Med 48(1–2):89–102 Pandey S (2024) Metabolomics characterization of disease markers in diabetes and its associated pathologies. Metab Syndr Relat Disord 22:499–509 Pandey S, Adnan Siddiqui M, Fau-Azim A, Azim A, Fau-Trigun SK, Trigun SK, Fau-Sinha N, Sinha N (2021) Serum metabolic profiles of septic shock patients based upon co-morbidities and other underlying conditions. Mol Omics. 17(2):260–76 Pandey S, Azim A, Sinha N (2023) Longitudinal NMR based serum metabolomics to track the potential serum biomarkers of septic shock. Nanotheranostics. 7(2):142–151 Pandey S, Siddiqui MA, Azim A, Sinha N (2023) Metabolic fingerprint of patients showing responsiveness to treatment of septic shock in intensive care unit. Magn Reson Mater Phys Biol Med 36(4):659–669 Pandey S, Siddiqui MA, Trigun SK, Azim A, Sinha N (2022) Gender-specific association of oxidative stress and immune response in septic shock mortality using NMR-based metabolomics. Mol Omics. 18(2):143–153 Siddiqui MA, Pandey S, Azim A, Sinha N, Siddiqui MH (2020) Metabolomics: an emerging potential approach to decipher critical illnesses. Biophys Chem 267:106462 Pandey SS (2024) Management and advances in metabolomics. Nanotheranostics 8(3):270–84 Pandey S (2024) Advances in metabolomics in critically ill patients with Sepsis and Septic Shock. Clin Exp Emerg Med. https://doi.org/10.15441/ceem.24.211 Anamika SMAS, Swarnima P, Afzal A, Neeraj S (2024) Unveiling pathophysiological insights: serum metabolic dysregulation in acute respiratory distress syndrome patients with acute kidney injury. J Proteome Res. https://doi.org/10.1021/acs.jproteome.4c00138 Dutta M, Joshi M, Fau-Srivastava S, Srivastava S, Fau-Lodh I, Lodh I, Fau-Chakravarty B, Chakravarty B, Fau-Chaudhury K, Chaudhury K (2012) A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis. Mol Biosyst. 8:3281–7 Jana SK, Dutta M, Joshi M, Srivastava S, Chakravarty B, Chaudhury K (2013) 1H NMR based targeted metabolite profiling for understanding the complex relationship connecting oxidative stress with endometriosis. Biomed Res Int 2013:329058 Butler LM, Perone Y, Dehairs J, Lupien LE, de Laat V, Talebi A et al (2020) Lipids and cancer: emerging roles in pathogenesis, diagnosis and therapeutic intervention. Adv Drug Deliv Rev 159:245–293 Wang FQ, Ariztia EV, Boyd LR, Horton FR, Smicun Y, Hetherington JA et al (2010) Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity. Gynecol Oncol 117(1):88–95 Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D’Ascenzo S et al (2005) Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res 65(20):9369–9376 Vouk K, Hevir N, Fau-Ribić-Pucelj M, Ribić-Pucelj M, Fau-Haarpaintner G, Haarpaintner G, Fau-Scherb H, Scherb H, Fau-Osredkar J, Osredkar J, Fau-Möller G et al (2012) Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis. Hum Reprod. 27:2955–65 Cordeiro FB, Cataldi TR, Perkel KJ, do Vale Teixeira da Costa L, Rochetti RC, Stevanato J et al (2015) Lipidomics analysis of follicular fluid by ESI-MS reveals potential biomarkers for ovarian endometriosis. J Assist Reprod Genet. 32(12):1817–25 Dutta M, Anitha M, Smith PB, Chiaro CR, Maan M, Chaudhury K et al (2016) Metabolomics reveals altered lipid metabolism in a mouse model of endometriosis. J Proteome Res 15(8):2626–2633 Dominguez F, Ferrando M, Diaz-Gimeno P, Quintana F, Fernandez G, Castells I et al (2017) Lipidomic profiling of endometrial fluid in women with ovarian endometriosisdagger. Biol Reprod 96(4):772–779 Sun Z, Fau-Song J, Song J, Fau-Zhang X, Zhang X, Fau-Wang A, Wang A, Fau-Guo Y, Guo Y, Fau-Yang Y, Yang Y, Fau-Wang X et al (2018) Novel SWATH(TM) technology for follicular fluid metabolomics in patients with endometriosis. Pharmazie. 1:318–32 Starodubtseva N, Chagovets V, Borisova A, Salimova D, Aleksandrova N, Chingin K et al (2019) Identification of potential endometriosis biomarkers in peritoneal fluid and blood plasma via shotgun lipidomics. Clin Mass Spectrom. 13(21–26):21–26 Chagovets VV, Wang Z, Kononikhin AS, Starodubtseva NL, Borisova A, Salimova D et al (2017) Endometriosis foci differentiation by rapid lipid profiling using tissue spray ionization and high resolution mass spectrometry. Sci Rep 7(1):2546 Wu MH, Lu CW, Chuang PC, Tsai SJ (2010) Prostaglandin E2: the master of endometriosis? Exp Biol Med (Mayw) 235(6):668–677 Chrobak A, Sieradzka U, Fau-Sozański R, Sozański R, Fau-Chełmońska-Soyta A, Chełmońska-Soyta A, Fau-Gabryś M, Gabryś M, Fau-Jerzak M, Jerzak M (2009) Ectopic and eutopic stromal endometriotic cells have a damaged ceramide signaling pathway to apoptosis. Fertil Steril. 92(6):1835–43 Vicente-Muñoz S, Morcillo I, Puchades-Carrasco L, Payá V, Pellicer A, Pineda-Lucena A (2016) Pathophysiologic processes have an impact on the plasma metabolomic signature of endometriosis patients. Fertil Steril 106:1733–1741 Braga DA-O, Montani DA-O, Setti AS, Turco EGL, Oliveira-Silva DA-O, Borges E Jr (2019) Metabolomic profile as a noninvasive adjunct tool for the diagnosis of Grades III and IV endometriosis-related infertility. Mol Reprod Dev. 86:1044–52 Zheng R, Du X, Lei Y (2023) Correlations between endometriosis, lipid profile, and estrogen levels. Med (Baltim) 102(29):e34348 Yang BC, Liu FY, Wang LQ, Zou Y, Wang F, Deng W, Huang OP (2015) Serum metabolic profiling study of endometriosis by using wooden-tip electrospray ionization mass spectrometry. Anal Methods 7(15):6125–6132 Vouk K, Ribic-Pucelj M, Adamski J, Rizner TL (2016) Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelins in peritoneal fluid from ovarian endometriosis patients. J Steroid Biochem Mol Biol 159:60–69 Lee YH, Tan CW, Venkatratnam A, Tan CS, Cui L, Loh SF et al (2014) Dysregulated sphingolipid metabolism in endometriosis. J Clin Endocrinol Metab 99(10):E1913–E1921 Lee YH, Yang JX, Allen JC, Tan CS, Chern BSM, Tan TY et al (2018) Elevated peritoneal fluid ceramides in human endometriosis-associated infertility and their effects on mouse oocyte maturation. Fertil Steril 110:767–777 Castiglione Morelli MA, Iuliano A, Schettini SCA, Petruzzi D, Ferri A, Colucci P et al (2019) NMR metabolic profiling of follicular fluid for investigating the different causes of female infertility: a pilot study. Metabolomics 15(2):19 Marianna S, Alessia P, Susan C, Francesca C, Angela S, Francesca C et al (2017) Metabolomic profiling and biochemical evaluation of the follicular fluid of endometriosis patients. Mol Biosyst 13(6):1213–1222 Vicente-Munoz S, Morcillo I, Puchades-Carrasco L, Paya V, Pellicer A, Pineda-Lucena A (2015) Nuclear magnetic resonance metabolomic profiling of urine provides a noninvasive alternative to the identification of biomarkers associated with endometriosis. Fertil Steril 104(5):1202–1209 Bozdag G, Igci N, Calis P, Ayhan B, OzelDemiralp D, Mumusoglu S et al (2019) Examination of cervical swabs of patients with endometriosis using Fourier transform infrared spectroscopy. Arch Gynecol Obstet 299(5):1501–1508 Funding Not applicable. Author information Authors and Affiliations Contributions Conception, design, analysis and interpretation of data, drafting the article, and final approval of the version to be published by Swarnima Pandey. Corresponding author Ethics declarations Conflict of interest Authors have no conflicts of interest to declare. Ethics approval Not applicable Consent to participate Not applicable Consent for publication Yes Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. About this article Cite this article Pandey, S. Metabolomics for the identification of biomarkers in endometriosis. Arch Gynecol Obstet 310, 2823–2827 (2024). https://doi.org/10.1007/s00404-024-07796-5 Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s00404-024-07796-5